v3.26.1
Composition of Certain Consolidated Financial Statement Line Items (Tables)
6 Months Ended
Jun. 30, 2026
Composition of Certain Consolidated Financial Statement Line Items  
Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

JUNE 30, 

DECEMBER 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Accrued compensation

$

8,013

$

12,434

Accrued research and development expenses

 

17,348

 

12,404

Accrued clinical expenses

22,015

15,791

Accrued professional services

3,138

4,470

Accrued other liabilities

 

1,873

 

1,444

Total accrued expenses and other current liabilities

$

52,387

$

46,543